Related Experiment Video
Updated: May 19, 2026

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
High cholesterol diet effects on ischemia-reperfusion injury of the heart
Verónica D'Annunzio1, Martín Donato, Bruno Buchholz
1Institute of Cardiovascular Physiopathology, Department of Pathology, Faculty of Medicine, University of Buenos Aires, Argentina.
Insights
High-cholesterol diets impact heart function and ischemia-reperfusion injury. Cardioprotection studies in hypercholesterolemic models yield controversial results due to diet and species variations.
Area of Science:
- Cardiovascular Science
- Dietary Impact on Cardiac Health
- Ischemia-Reperfusion Injury Mechanisms
Background:
- Ischemic heart disease is a major cause of death globally.
- Hypercholesterolemia is a key factor in myocardial ischemia development.
- Understanding ischemia-reperfusion injury and cardioprotection is crucial.
Purpose of the Study:
- To review the effects of high-cholesterol diets on ventricular function.
- To investigate ischemia-reperfusion injury and post-ischemic dysfunction (stunned myocardium).
- To analyze controversial findings in hypercholesterolemic models regarding cardioprotection.
Main Methods:
- Literature review focusing on studies of high-cholesterol diets and cardiac function.
- Analysis of experiments involving hypercholesterolemic animal models.
- Evaluation of cardioprotective strategies like preconditioning, postconditioning, and statins.
Main Results:
- Studies on normal animals are abundant, but hypercholesterolemic models show controversial results.
- Cardioprotection mechanisms (preconditioning, postconditioning, statins) yield varied outcomes in hypercholesterolemic states.
- Results depend heavily on diet quality, composition, timing, and animal species.
Conclusions:
- High-cholesterol diet effects on cardiac function and injury are complex and model-dependent.
- Variability in experimental design (diet, species) explains conflicting cardioprotection findings.
- Careful consideration of these variables is essential for interpreting and comparing research on hypercholesterolemia and cardiac protection.
Abstract:
Ischemic heart disease is the leading cause of morbi-mortality in developed countries. Both ischemia-reperfusion injury and mechanisms of cardioprotection have been studied for more than 50 years. It is known that the physiopathological mechanism of myocardial ischemia involves several factors that are closely related to its development, of which hypercholesterolemia is one of the main ones. Therefore, the objective of this review was to elucidate the effects of a high-cholesterol diet on normal ventricular function and ischemia-reperfusion injury associated phenomenon such as post-ischemic ventricular dysfunction (stunned myocardium). Although there exist many studies considering several aspects of this physiopathological entity, the majority were carried out on normal animals. Thus, experiments carried out on hypercholesterolemic models are controversial, in particular those evaluating different mechanisms of cardioprotection such as ischemic preconditioning and postconditioning, and cardioprotection granted by drugs such as statins, which apart from exerting a lipid-lowering effect, exert pleiotropic effects providing cardioprotection against ischemia-reperfusion injury. These controversial results concerning the mechanisms of cardioprotection vary according to quality, composition, and time of administration of the high-cholesterol diet, as well as the species used in each experiment. Thus, to compare the results it is necessary to take all of these variables into account, since they can change the obtained results.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Atherosclerosis III: Management

